Category Archives: Meetings

The Rising Clout of the Patient

by Sarah Krüg In 2011, the patient’s clout as a stakeholder was firmly established, as reflected in several industry conferences. What’s next for the patient in 2012?
Also posted in Events, leadership, Patient Communication, patient education, social media, Strategy, Technology | Tagged , , | 1 Comment

The Rise of the Patient: Medicine 2.0

by Sarah Krüg Amidst yellow sandstone arches and California Mission Revival architecture, The Medicine 2.0 +Stanford Summit (otherwise known as the Fourth World Congress on Social Media and Web 2.0 in Health Medicine) set out on a three day journey to challenge its diverse audience to break down silos and expand beyond traditional boundaries. From […]
Also posted in healthcare, leadership, Patient Communication, patient compliance, patient education, social media, Strategy, Technology | Tagged , | 1 Comment

DIA: Social Media Guidelines are DDMAC’s "Highest Priority"

Tom Abrams, director of FDA’s Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), said that publishing social media guidelines for industry is the division’s “highest priority,” and that the document will be “published as soon as it’s vetted.”
Also posted in Advertising, E-Media, FDA, Marketing, patient education, Regulatory, social media, Strategy, Technology | Tagged , , | 1 Comment

Gift Giving Must Stop Says ProPublica

According to ProPublica—though transparency has seemingly increased between pharma and physicians since the Christmastime release of its Dollars for Docs report—medical societies and organizations are still having a holiday with industry money. Three days before Christmas last year, independent news organization ProPublica released its own “naughty and nice” list in the form of its Dollars […]
Also posted in Regulatory | Tagged , , , | 1 Comment

Fighting Cancer — A Checklist of Change

Payer and regulatory pressures are likely to take some steam off of heady projections of market growth in this sensitive therapeutic area. Against a backdrop of new figures detailing the mounting cost of fighting cancer, Pharm Exec’s sister CBI conference unit held its annual meeting — co-chaired by Alison Ayers of Pfizer and Ben Steinmetz […]
Also posted in FDA, Global, healthcare, Regulatory, Safety | 1 Comment
  • Categories

  • Meta